Catalyst OrthoScience
Early stage medical device company that is bringing the catalyst csr total shoulder to market.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 Valuation: €0.0 | round | |
* | $20.0m | Late VC | |
| Total Funding | 000k | ||
Related Content
Catalyst OrthoScience, founded in 2014 by orthopedic surgeon Steven Goldberg, MD, is a medical device company that has developed a novel shoulder replacement system. The company's flagship product, the Catalyst CSR™ Total Shoulder System, is engineered to make shoulder arthroplasty procedures less invasive and more efficient for surgeons.
The system is designed to enhance precision and bone preservation, aiming to provide patients with a more natural-feeling shoulder joint post-surgery. Catalyst OrthoScience targets orthopedic surgeons as its primary clients, operating within the broader orthopedic and medical device market.
The company's business model revolves around the sale of its specialized shoulder replacement systems to healthcare facilities and surgeons. Recently, the company announced it had surpassed 10,000 total shoulder arthroplasty procedures and secured an additional $20 million in financing, indicating a strong growth trajectory and market adoption.
Keywords: medical device, orthopedics, shoulder replacement, arthroplasty, surgical instruments, healthcare, medical technology, joint replacement, surgical innovation, orthopedic implants